Filing Details

Accession Number:
0000905148-24-000585
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-12 21:45:35
Reporting Period:
2024-02-08
Accepted Time:
2024-02-12 21:45:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1439725 Biodesix Inc BDSX Services-Medical Laboratories (8071) 203986492
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1828131 Kieran O'kane 919 West Dillon Rd
Louisville CO 80027
Chief Commercial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-08 32,024 $0.00 79,736 No 4 M Direct
Common Stock Disposition 2024-02-09 6,319 $1.92 73,417 No 4 S Direct
Common Stock Disposition 2024-02-12 5,412 $1.66 68,005 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Acquisiton 2024-02-08 64,381 $0.00 64,381 $0.00
Common Stock Stock Options (Right to buy) Acquisiton 2024-02-08 128,761 $0.00 128,761 $1.99
Common Stock Restricted Stock Units Disposition 2024-02-08 1,490 $0.00 1,490 $0.00
Common Stock Restricted Stock Units Disposition 2024-02-08 30,534 $0.00 30,534 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
64,381 No 4 A Direct
128,761 2034-02-07 No 4 A Direct
11,915 No 4 M Direct
91,601 No 4 M Direct
Footnotes
  1. Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  2. These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
  3. The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.8191 to $2.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $1.55 to $1.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
  6. This option vests in a series of forty-eight successive equal monthly installments measured from January 15, 2024, generally subject to the Reporting Person's continuous service through each applicable vesting date.
  7. These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
  8. These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.